ES8506267A1 - Un procedimiento para preparar un compuesto relacionado con la espergualina - Google Patents

Un procedimiento para preparar un compuesto relacionado con la espergualina

Info

Publication number
ES8506267A1
ES8506267A1 ES525278A ES525278A ES8506267A1 ES 8506267 A1 ES8506267 A1 ES 8506267A1 ES 525278 A ES525278 A ES 525278A ES 525278 A ES525278 A ES 525278A ES 8506267 A1 ES8506267 A1 ES 8506267A1
Authority
ES
Spain
Prior art keywords
group
alpha
amino acid
spergualin
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES525278A
Other languages
English (en)
Other versions
ES525278A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of ES525278A0 publication Critical patent/ES525278A0/es
Publication of ES8506267A1 publication Critical patent/ES8506267A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UN COMPUESTO RELACIONADO CON LA ESPERGUALINA.COMPRENDE SEPARAR GRUPOS PROTECTORES DE UN COMPUESTO RELACIONADO CON LA ESPERGUALINA DE FORMULA (II) Y OBTENER EL COMPUESTO DESEADO DE FORMUAL (I) DONDE R1 REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO HIDROXILO O UN GRUPO ACILOXI ALIFATICO CON C 1 A 10; R2 REPRESENTA UN RESTO A O V-AMINOACIDO; Y M REPRESENTA UN ENTERO DE 4 A 6. LA OPERACION SE REALIZA MEDIANTE REDUCCION CON HIDROGENO EN PRESENCIA DE NEGRO O PALADIO EN UN ALCOHOL INFERIOR, A UNA TEMPERATURA ENTRE LA AMBIENTE Y 50JC, Y A UNA PRESION DESDE LA ATMOSFERICA HASTA 100 KG/CM, O POR TRATAMIENTO CON ACIDO TRIFLUOROACETICO A 0JC Y A PRESION ATMOSFERICA.
ES525278A 1982-09-02 1983-08-31 Un procedimiento para preparar un compuesto relacionado con la espergualina Expired ES8506267A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57151698A JPS5942356A (ja) 1982-09-02 1982-09-02 スパガリン関連化合物およびその製造法

Publications (2)

Publication Number Publication Date
ES525278A0 ES525278A0 (es) 1985-07-01
ES8506267A1 true ES8506267A1 (es) 1985-07-01

Family

ID=15524303

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525278A Expired ES8506267A1 (es) 1982-09-02 1983-08-31 Un procedimiento para preparar un compuesto relacionado con la espergualina

Country Status (14)

Country Link
US (1) US4529549A (es)
EP (1) EP0105193B1 (es)
JP (1) JPS5942356A (es)
KR (1) KR900008137B1 (es)
AR (1) AR241650A1 (es)
AT (1) ATE36701T1 (es)
AU (1) AU560073B2 (es)
CA (1) CA1199641A (es)
CS (1) CS235341B2 (es)
DE (1) DE3377795D1 (es)
DK (1) DK160089C (es)
ES (1) ES8506267A1 (es)
HU (1) HU190730B (es)
MX (1) MX8257A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862152A (ja) * 1981-10-08 1983-04-13 Microbial Chem Res Found Ｎ−〔４−（３−アミノプロピル）アミノブチル〕−２−（ω−グアニジノ脂肪酸アミド）−２−ヒドロキシエタンアミドおよびその誘導体ならびにその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
JPS61165322A (ja) * 1985-01-14 1986-07-26 Microbial Chem Res Found スパガリン類の注射用凍結乾燥製剤
JPH075538B2 (ja) * 1985-08-27 1995-01-25 財団法人微生物化学研究会 フエニレン基を有するスパガリン関連ニトリル化合物及びその製造法
ATE64378T1 (de) * 1986-04-04 1991-06-15 Microbial Chem Res Found Spergualinaehnliche verbindungen und ihr herstellungsverfahren.
AU584502B2 (en) * 1987-03-30 1989-05-25 Shosuke Okamoto Phenylalanine derivatives and proteinase inhibitor
JPH0794424B2 (ja) * 1987-09-30 1995-10-11 財団法人微生物化学研究会 新スパガリン関連化合物およびその製造法
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions
JPH0776204B2 (ja) * 1988-07-01 1995-08-16 寳酒造株式会社 スパガリン類の精製法
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
DE69104291T2 (de) * 1990-07-20 1995-05-18 Takara Shuzo Co Spergulinähnliche Verbindungen und ihre Verwendung.
WO1994004140A1 (en) * 1992-08-19 1994-03-03 Nippon Kayaku Kabushiki Kaisha Antiprotozoan drug
FR2698628B1 (fr) * 1992-12-02 1995-02-17 Fournier Ind & Sante Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2716452B1 (fr) * 1994-02-24 1996-05-10 Fournier Ind & Sante Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2716451B1 (fr) * 1994-02-24 1996-04-26 Fournier Ind & Sante Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2730488B1 (fr) * 1995-02-10 1997-04-30 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur utilisation en therapeutique et leur procede de preparation
US5883132A (en) * 1995-02-10 1999-03-16 Fournier Industrie Et Sante 15-deoxyspergualin analogs, their use in therapeutics and their method of preparation
FR2737891B1 (fr) * 1995-08-17 1997-10-24 Fournier Ind & Sante Analogues chiraux de la 15-deoxyspergualine, procede de preparation et utilisation en therapeutique
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737443A (en) * 1969-04-02 1973-06-05 Taiho Pharmaceutical Co Ltd Omega-guanidino acid amide derivatives and manufacturing the same
JPS507057B1 (es) * 1970-10-28 1975-03-20
US3937805A (en) * 1971-11-10 1976-02-10 Colgate-Palmolive Company Method of making dentifrice compositions containing insolubilized salts of 1,6-di-(p-chlorophenyl biguanido) hexane
JPS5748957A (en) * 1980-09-08 1982-03-20 Microbial Chem Res Found Novel antibiotic bmg 162-af2, its preparation and carcinostatic agent comprising it as active ingredient
CH648289A5 (de) * 1981-05-11 1985-03-15 Microbial Chem Res Found N-(4-(3-aminopropyl)-aminobutyl)-2,2-dihydroxyaethanamid und verfahren zu seiner synthese.

Also Published As

Publication number Publication date
CA1199641A (en) 1986-01-21
DK160089C (da) 1991-06-24
CS235341B2 (en) 1985-05-15
KR900008137B1 (ko) 1990-10-31
HU190730B (en) 1986-10-28
ES525278A0 (es) 1985-07-01
JPH0149256B2 (es) 1989-10-24
KR840006332A (ko) 1984-11-29
JPS5942356A (ja) 1984-03-08
EP0105193A3 (en) 1985-04-03
DK160089B (da) 1991-01-28
AR241650A1 (es) 1992-10-30
EP0105193B1 (en) 1988-08-24
AU1807483A (en) 1984-03-08
MX8257A (es) 1994-01-31
US4529549A (en) 1985-07-16
AU560073B2 (en) 1987-03-26
EP0105193A2 (en) 1984-04-11
DK398583A (da) 1984-03-03
DE3377795D1 (en) 1988-09-29
DK398583D0 (da) 1983-09-01
ATE36701T1 (de) 1988-09-15

Similar Documents

Publication Publication Date Title
ES8506267A1 (es) Un procedimiento para preparar un compuesto relacionado con la espergualina
WO1987000523A3 (fr) Hydroxyalkylxanthines tertiaires, leur procede de fabrication, medicaments les contenant et leur utilisation
NZ237132A (en) Preparation of substituted oxetanones from beta-hydroxy-omega-lactones; various beta-hydroxy and beta-keto-omega-lactones
EP0322242A3 (en) Adenosine derivatives
EP0168832A3 (en) Pharmaceutical composition containing a tetrapyrrole compound as active ingredient and process for the production of the tetrapyrrole compound
EP0358154A3 (en) Novel cyclobutane derivative and process for producing same
HUT47128A (en) Process for producing oxetanocins and pharmaceutical compositions comprising such compounds
ES479168A1 (es) Un procedimiento para la preparacion de derivados de acido 7&-metoxicefalosporanico.
CA1047032A (en) Adriamycin esters
HU196816B (en) Process for producing alkali- and ammonium-salts of 4-/hydroxy-methyl-phosphinyl/-2-amino-butiric acid
ES8401068A1 (es) Procedimiento para la preparacion de derivados de corinanteina, asi como de sus sales de adicion acida fisiologicamente inocuas.
ES8702425A1 (es) Un metodo para preparar un acido fosforico.
EP0277599A3 (en) Fluorine containing cyclopentane derivatives and processes for their production
DE3261515D1 (en) Benzopyranyl ethers, process for their preparation and medicine containing those compounds and intermediates
ES8300685A1 (es) Procedimiento para la produccion de pentapeptidos
GB2009180A (en) 25-Alkyl Cholesterol Derivatives
ES8303450A1 (es) "procedimiento para la preparacion de 17a-alcohil-17b-hidroxi-1a-metil-4-androsten-3-onas".
EP0220381A3 (en) Process for synthesis of aluminum coordination compounds
ES466245A1 (es) Procedimiento para preparar derivados de isoquinolina
ES8502107A1 (es) Un procedimiento para la preparacion de un isocromano.
ES8401059A1 (es) Procedimiento para la preparacion de fenoleteres biciclicos.
GB1445668A (en) Process for obtaining the optical isomers of penicillamine
DE3174614D1 (en) Pharmaceutical compositions containing androstenes
JPS51125363A (en) Process for freparation of alkylidenebiscyclohexylamines
GB1565413A (en) Sulphur-containing n-(o-nitro-benzyl)-amino acids adn esters

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20041102